Five Prime Therapeutics, Inc. Deferred Revenue (Non-Current)
Five Prime Therapeutics, Inc. had Deferred Revenue (Non-Current) of $10.81 million as of 2018-06-30, per its 10-Q filed 2018-08-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2018-08-08
- 2018-06-30: Deferred Revenue, Noncurrent $10.81M.
- 2018-03-31: Deferred Revenue, Noncurrent $14.82M.
- 2017-12-31: Deferred Revenue, Noncurrent $10.22M.
- 2017-09-30: Deferred Revenue, Noncurrent $9.44M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2018-06-30 | $10.81M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $14.82M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $10.22M 10-Q · filed 2018-08-08 |
| 2017-09-30 | $9.44M 10-Q · filed 2017-11-06 |
| 2017-06-30 | $12.03M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $14.63M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $17.86M 10-K · filed 2018-02-27 |
| 2016-09-30 | $21.21M 10-Q · filed 2016-11-04 |
| 2016-06-30 | $24.56M 10-Q · filed 2016-08-05 |
| 2016-03-31 | $27.91M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $31.27M 10-K · filed 2017-02-24 |
| 2015-09-30 | $45.17M 10-Q · filed 2015-11-05 |
| 2015-06-30 | $46.80M 10-Q · filed 2015-08-07 |
| 2015-03-31 | $48.54M 10-Q · filed 2015-05-14 |
| 2014-12-31 | $48.63M 10-K · filed 2016-03-11 |
| 2014-09-30 | $20.92M 10-Q · filed 2014-11-12 |
| 2014-06-30 | $22.96M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $25.50M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $7.12M 10-K · filed 2015-03-18 |
| 2013-09-30 | $8.42M 10-Q · filed 2013-11-13 |
| 2012-12-31 | $7.26M 10-K · filed 2014-03-26 |